Dr. Michael Chan received his PhD degree in Medical Science from the Chinese University of Hong Kong, followed by the post-doctoral fellowships in influenza research at the University of Hong Kong in 2004.
Dr. Chan main research interests are the virus-host interaction and pathogenesis of influenza virus and SARS and MERS coronavirus using ex vivo human respiratory explant cultures and in vitro well-differentiated human respiratory epithelial cells. Major focuses of his current work are: (1) Risk assessment of influenza virus and coronavirus using ex vivo explants and in vitro respiratory epithelial cells model. (2) Mechanism of lung injury upon severe influenza virus and coronavirus infection (3) Role of human distal airway stem cells in respiratory epithelium regeneration upon influenza H5N1 virus, SARS and MERS-CoV infection. (4) Role of mesenchymal stromal cells in reverse influenza H5N1 associated acute lung injury (5) Novel therapeutic agents for severe influenza virus and coronavirus infection
Dr. Chan is ranked by Essential Science Indicator (ISI) as a “top 1% most-cited international scientist” in the world. He has published over 60 manuscripts; many of them are in high impact journals including Lancet Respiratory Medicine, Nature Medicine, PNAS, European Respiratory Journal, PLoS Pathogens, Journal of Virology, Respiratory Research and Gastroenterology which are among the top peer-reviewed scientific journals.
Dr. Chan has received research funding as a Principal Investigator from various local and oversea research organizations, including NIAID-CEIRS (USA), Theme-based Research Scheme, Area of Excellence Scheme and GRF (RGC, Hong Kong), ITF grant (ITC, Hong Kong), HMRF (Hong Kong). Since 2005, Dr. Chan has secured research funding with a total amount of over HK$ 38 million. In addition, he has trained and currently training 12 postgraduate research students.
Dr. Chan has worked as the visiting scientists in the Department of Anesthesia and Medicine, Centre for Regenerative Studies, Brigham and Women's Hospital, Harvard Medical School and the Cardiovascular Research Institute, University of California, San Francisco. Furthermore, he is an Academic Editor of PLoS ONE, Associate Editor of Frontiers in Microbiology and the editorial broad member of the Open Journal of Respiratory diseases, International Journal of Clinical and Experimental Pathology and Medicine. He reviews manuscripts regularly for various international peer-review top tier journals.
Hui KPY, Chan LLY, Kuok DIT, Mok CKP, Yang Z, Li R, Luk GS, Lee EF, Lai JCC, Yen HL, Zhu H, Guan Y, Nicholls JM, Peiris JSM, Chan MCW (2017) Tropism and innate host responses of influenza A/H5N6 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. European Respiratory Journal. In Press (Impact factor: 10.6; citation: 1).
Chan MCW, Kuok DIT, Leung CYH, Hui KPY, Valkenburg SA, Lau EHY, Nicholls JM, Fang X, Guan Y, Lee JW, Chan RWY, Webster RG, Matthay MA, Peiris JSM (2016) Human mesenchymal stromal cells reduce influenza A H5N1–associated acute lung injury in vitro and in vivo. Proc Natl Acad Sci U S A. 113(13): 3621-6. (Impact Factor: 9.7; citation: 11).
Hui KPY, Kuok DIT, Kang SS, Li HS, Ng MM, Bui CH, Peiris JSM, Chan RWY,Chan MCW (2015)Modulation of sterol biosynthesis regulates viral replication and cytokine production in influenza A virus infected human alveolar epithelial cells. Antiviral Research, 119:1-7. (Impact factor: 4.9; citation: 1)
Mok CKP, Kang SS, Chan RWY, Yue PY, Mak NK, Poon LLM, Wong RN, Peiris JSM, Chan MCW (2014) Anti-inflammatory and antiviral effects of indirubin derivatives in influenza A (H5N1) virus infected primary human peripheral blood-derived macrophages and alveolar epithelial cells. Antiviral Research.106: 95-104. (Impact Factor: 4.9; citation: 10)
Chan MCW, Chan RWY, Chan LLY, Mok CKP, Hui KPY, Fing JHM, Tao KP, Poon LLM, Nicholls JM, Guan Y, Peiris JSM (2013) Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract. Lancet Respiratory Medicine. 1(7) 534 – 542. (Impact Factor: 19.3; citation: 38)
Chan RWY, Kang SS, Yen HL, Li AC, Tang LS, Yu WC, Yuen KM, Chan IW, Wong DD, Lai WW, Kwong DL, Sihoe AD, Poon LL, Guan Y, Nicholls JM, Peiris JSM, Chan MCW (2011) Tissue tropism of swine influenza viruses and reassortants in ex vivo cultures of the human respiratory tract and conjunctiva. Journal of Virology, 85(22):11581-7.(Impact factor: 4.7, citation: 14)
Yu WC, Chan RW, Wang J, Travanty EA, Nicholls JM, Peiris JSM, RJ Mason, Chan MCW (2011) Viral replication and innate host responses in primary human alveolar epithelial cells and alveolar macrophages infected with influenza H5N1 and H1N1 viruses. Journal of Virology, 85(14):6844-55.(Impact factor: 4.7, citation: 61)
Chan MCW, Chan RW, Yu WC, Ho CC, Yuen KM, Fong JH, Tang LL, Lai WW, Lo AC, Chui WH, Sihoe AD, Kwong DL, Wong DS, Tsao GS, Poon LL, Guan Y, Nicholls JM, Peiris JS (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. The American Journal of Pathology. 176(4):1828-40.(Impact factor: 4.59, citations: 71)
Nicholls JM*, Chan MCW*, Chan RWY*, Wong HK, Cheung CY, Kwong DLW, Wong MP, Chui WH, Poon LLM, Tsao SW, Guan Y, Peiris JSM (2006) Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Medicine 13(2), 147-149. *Authors equally contributed.(Impact factor: 30.36, citation: 224)
Chan MCW, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO, Chan RWY, Guan Y, Peiris JSM (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respiratory Research 6: 135-147.(Impact factor: 3.76. citation: 301)